SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Lustig Garrett (Last) (First) (Middle) C/O ORGANOGENESIS HOLDINGS INC. 85 DAN ROAD (Street) CANTON MA 02021 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 11/12/2024	3. Issuer Name and Ticker or Trading Symbol Organogenesis Holdings Inc. [ ORGO ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner Officer (give title below) Other (specify below)	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Common Stock	27,339	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 Power of Attorney filed herewith.

	/s/ William R. Kolb, Attorney-in-Fact	11/14/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

	KNOW ALL BY THESE PRESENTS, that the undersigned
hereby constitutes and appoints Lori Freedman, William R. Kolb,
Stacie S. Aarestad and Ryan M. Rourke Reed, and each of them
individually, as the undersigned's true and lawful
attorney-in-fact, to (i) prepare, execute in the undersigned's
name and on the undersigned's behalf, and submit to the U.S.
Securities and Exchange Commission (the "SEC") a Form ID,
including amendments thereto, and any other documents necessary
or appropriate to obtain codes and passwords enabling the
undersigned to make electronic filings with the SEC of reports
required by Section 16(a) of the Securities Exchange Act of 1934,
as amended, or any rule or regulation of the SEC; (ii) execute
for and on behalf of the undersigned, in the undersigned's
capacity as officer and/or director of Organogenesis Holdings Inc.
(the "Company"), Forms 3, 4, and 5 in accordance with Section 16(a)
of the Securities Exchange Act of 1934, as amended, and the rules
thereunder; (iii) do and perform any and all acts for and on behalf
of the undersigned that may be necessary or desirable to complete
and execute any such Form 3, 4, or 5, complete and execute any
amendment or amendments thereto, and timely file such form with
the SEC and any stock exchange or similar authority; and (iv) take
any other action of any type whatsoever in connection with the
foregoing that, in the opinion of each such attorney-in-fact,
may be of benefit to, in the best interest of, or legally required
by, the undersigned, it being understood that the documents
executed by each such attorney-in-fact on behalf of the undersigned
pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as each such attorney-in-fact may
approve in each such attorney-in-fact's discretion. The undersigned
hereby grants to each such attorney-in-fact full power and authority
to do and perform any and every act and thing whatsoever requisite,
necessary or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as
the undersigned might or could do personally present, with full
power of substitution, resubstitution or revocation, hereby ratifying
and confirming all that each such attorney-in-fact, or each such
attorneys-in-fact's substitute or substitutes, shall lawfully do
or cause to be done by virtue of this power of attorney and the
rights and powers herein granted. The undersigned acknowledges
that each foregoing attorney-in-fact, in serving in such capacity
at the request of the undersigned, is not assuming any of the
undersigned's responsibilities to comply with Section 16 of the
Securities Exchange Act of 1934, as amended.

	This Power of Attorney shall remain in full force and effect
until the undersigned is no longer required to file Forms 3, 4, or 5
with respect to the undersigned's holdings of and transactions in
securities issued by the Company, unless earlier revoked by the
undersigned in a signed writing delivered to each foregoing
attorney-in-fact.


     IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of this 7th day of November, 2024.

/s/ Garrett Lustig
Name: Garrett Lustig